LXR agonist improves peripheral neuropathy and modifies PNS immune cells in aged mice.

Chaitanya K GaviniNadia ElshareifGregory AubertAnand V GermanwalaNigel A CalcuttVirginie M Aubert

Published in: Journal of neuroinflammation (2022)

These results suggest that activation of the LXR may delay the PNS aging by modifying nerve-immune cell lipid content. Our study provides new potential targets to treat or delay neuropathy during aging.

Keyphrases

fatty acid
risk assessment